Having examined stem and progenitor cell quality and quantity in CD49f and CD24 variably expressing populations using a TaqMan Human Stem Cell Pluripotency Array Micro Fluidic Card and surrogate mammosphere assays in previous work [23], we herein sought to directly compare metabolic profiles of these stem and progenitor-like cell subpopulations between breast cancer specimens and benign breast tissues. The gene discussed is CD24; the disease is breast carcinoma.